We appreciate that you have provided us with personal information, we will never sell your data to anyone else and data is for the use of ViiV Healthcare only. If you would like to find out more, please visit our Terms & Conditions and Privacy Policy.
For Belgium:
Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use (BCPH) of the Federal Agency for Medicines and Health Products (FAMHP) on the following address: adversedrugreactions@afmps.be or via the ‘yellow card’ available on the website HYPERLINK "http://www.fagg-afmps.be/"http://www.fagg-afmps.be or to ViiV HealthCare sprl/bvba at the number 010/ 85 65 00.
For Luxembourg:
for Luxemburg Adverse events: Please report adverse events to the ‘Ministère de la Santé du Grand-Duché du Luxembourg (Division de la Pharmacie et des Médicaments)’ at the fax number +35 2 24795615 or by postal mailing) or at the ‘Centre Régional de Pharmacovigilance de Lorraine’ (fax number +33 3 83 32 33 44 or crpv@chu-nancy.fr) or to ViiV Healthcare sprl/bvba at the number 0032 10/85 65 00.
